Sign in

CIK 0001262104 · Non-accelerated filer<br>Smaller reporting company

Lite Strategy, Inc.

Sign in to watch
Ticker
LITS
Exchange
Nasdaq
Industry
Finance Services
FY end
Jun 30
Incorporated
DE
Entity type
operating
EIN
510407811
Phone
858-369-7100
Business address
9920 PACIFIC HEIGHTS BLVD, SUITE 150, SAN DIEGO, CA, 92121
Former names
MEI Pharma, Inc., MARSHALL EDWARDS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 68 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-10-20 Funicular Funds, LP 10% owner Other disposition · Put Option (obligation to buy) −4,494 0
2023-10-20 Anson Funds Management LP 10% owner Option exercise +143,200 $7.00 $1.0M 1,057,388
2023-10-20 Anson Funds Management LP 10% owner Option exercise +35,800 $7.00 $251K 1,093,188
2023-10-20 Anson Funds Management LP 10% owner Option exercise · Put Option (obligation to buy) −1,432 7,068
2023-10-20 Anson Funds Management LP 10% owner Option exercise · Put Option (obligation to buy) −358 6,710
2023-10-20 Anson Funds Management LP 10% owner Other disposition · Put Option (obligation to buy) −6,710 0
2023-10-11 Funicular Funds, LP 10% owner Option exercise +30,000 $7.00 $210K 490,840
2023-10-11 Funicular Funds, LP 10% owner Option exercise · Put Option (obligation to buy) −300 5,700
2023-10-11 Anson Funds Management LP 10% owner Option exercise +40,000 $7.00 $280K 904,188
2023-10-11 Anson Funds Management LP 10% owner Option exercise +10,000 $7.00 $70K 914,188
2023-10-11 Anson Funds Management LP 10% owner Option exercise · Put Option (obligation to buy) −400 8,600
2023-10-11 Anson Funds Management LP 10% owner Option exercise · Put Option (obligation to buy) −100 8,500
2023-09-29 Baltic Charles V. III Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2023-09-29 DRISCOLL FREDERICK W Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2023-09-29 Glover Nicholas Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2023-09-29 GOLD DANIEL P PHD Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2023-09-29 HOWSON TAMAR D Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2023-09-29 Reynolds Thomas C Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2023-09-29 KANGO SUJAY Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2023-09-29 GHALIE RICHARD G Chief Medical Officer Grant or award · Stock Option (Right to Buy) +30,000 30,000

Page 3 of 13 · 252 trades